Johnson RK et al. |
Stathmokinetic and therapeutic effects of maytansine in mice bearing P388 and L1210 leukemias. |
1978 |
Biochem. Pharmacol. |
pmid:708479
|
Friedkin M and Rozengurt E |
The role of cytoplasmic microtubules in the regulation of the activity of peptide growth factors. |
1980 |
Adv. Enzyme Regul. |
pmid:7039258
|
Borden EC et al. |
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas. |
1982 |
Am. J. Clin. Oncol. |
pmid:6956236
|
Sieber SM et al. |
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. |
1978 |
Teratology |
pmid:694777
|
Baskin F et al. |
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. |
1981 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6943568
|
Slavik M et al. |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience. |
1982 |
Am. J. Clin. Oncol. |
pmid:6897490
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6869315
|
Edmonson JH et al. |
Phase II study of maytansine in advanced sarcomas. |
1983 |
Cancer Treat Rep |
pmid:6850657
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6846245
|
deVere White R et al. |
Maytansine as a cause of acute proliferative disorder of bladder urothelium in the rat. |
1983 |
Cancer Treat Rep |
pmid:6825127
|